Dina has extensive experience as a pharmacokineticist and a medical writer in developing protocols for bioequivalence and Phase I studies in a multitude of therapeutic indications. After more than 10 years of experience in clinical research, Dina has helped clients with regulatory inquiries, and advised them on the best scientific approach to clinical study designs for submissions to the FDA, Health Canada, and within Europe. Dina holds a Master of Science in the field of Microbiology, where she contributed to the understanding of the pathology of meningitis. Dina is a member of the American Medical Writing Association.
